Scientists Alter Bacteria To Create Medicine
SAN FRANCISCO, Calif-Stanford University researchers are attempting to alter E. coli<$> bacteria in an effort to create erythromyacin-one of the most powerful antibiotics being used today.
They are altering the bacteria genetically to create the antibiotic because current methods of producing the drug are time-consuming. This specific bacterium was chosen because it grows rapidly. Altering its genetic foundation would give researchers a faster and less expensive method of creating mass amounts of the antibiotic.
By genetically altering the germ, scientists could also stay one step ahead of the ever-evolving world of germs. Each time a germ adapts to work around current antibacterial technology, scientists could in turn alter their mutation to their manufactured antibiotic.
A different ironic twist in the world of genetically altered treatments is developing with tobacco research. A different group of scientists is trying to alter the genetics of the leafy plant to create a new array of medicines to fight everything from cancer to tooth decay.
They estimate this group of drugs will be developed and a dominant aspect of US pharmacology within 10 years.
Information from www.sfgate.com
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
